1L. Mandelzweig,U. Goldbourt,H. Reicher-Reiss,S. Behar,E. Kaplinsky.Nifedipine does not improve survival in AMI patients without heart failure[J].Cardiovascular Drugs and Therapy.1993(1)
2Sweeney HL,F Feng HS,Yang Z,et al.Functional analyses of troponin T mutations thatcause hypertrophic cardiomyopathy:insights into disease pathogenesis and troponinfunction[J].J Lipid Res,1999,40:178-182.
3贾宏均,等.离子通道与心脏血管疾病:基础与临床[M].北京:人民卫生出版社,2001.
4Franklin. Prognostic value of the metabolic syndrome in essential hypertension[J]. JACC, 2004, 43: 449.
5Home PD.Rosiglitazone evaluated for cardiac outcomes and regulationof glycaemia in diabetes(RECORD):An interim analysis of glycaemia at 18 months [J]. European Association for the Study of Diabetes, 2004, 25: 725-734.
6St John Sutton M, Rendell M, Dandona P, et al. A comparison of the effect of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes mellitus[J].Diabetes Care, 2002, 25:2058-2064.
